OR10J9P

Across TCGA pan-cancer cohorts, OR10J9P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated OR10J9P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OR10J9P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR10J9P expression acts as an unfavorable survival marker, although some lineages such as SKCM and ESCA show a favorable association.

BLCA, BRCA, and THCA are the cancer types where OR10J9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.268	0.623	<.001	108	view →
BRCA	OS	Tertile	All	0.113	0.581	<.001	96	view →
THCA	OS	Tertile	II,III,IV	0.709	0.967	.001	39	view →
CESC	DFS	Tertile	II,III,IV	0.184	0.705	.036	36	view →
ACC	DFS	Tertile	All	0.068	0.667	.005	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	36	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	36	view →
SARC	OS	Tertile	All	0.449	0.831	.002	30	view →
SKCM	DFS	Tertile	II,III,IV	1.000	0.554	.008	27	view →
MESO	DFS	Tertile	III,IV	0.078	0.376	.012	27	view →
GBM	OS	Tertile	All	0.030	0.416	<.001	18	view →
TGCT	DFS	Tertile	All	0.035	0.837	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

OR10J9P–BLCA (DFS)

Open the BLCA breakdown →